These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 23046638

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
    Messa C, Ceresoli GL, Rizzo G, Artioli D, Cattaneo M, Castellone P, Gregorc V, Picchio M, Landoni C, Fazio F.
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of gross tumor size using CT, 18F-FDG PET, integrated 18F-FDG PET/CT and pathological analysis in non-small cell lung cancer.
    Yu HM, Liu YF, Hou M, Liu J, Li XN, Yu JM.
    Eur J Radiol; 2009 Oct; 72(1):104-13. PubMed ID: 18640802
    [Abstract] [Full Text] [Related]

  • 5. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
    Heusch P, Buchbender C, Köhler J, Nensa F, Beiderwellen K, Kühl H, Lanzman RS, Wittsack HJ, Gomez B, Gauler T, Schuler M, Forsting M, Bockisch A, Antoch G, Heusner TA.
    Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
    [Abstract] [Full Text] [Related]

  • 6. Clinical impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of small cell carcinoma of the prostate.
    Sahiner I, Akkas BE, Ucmak Vural G.
    Rev Esp Med Nucl Imagen Mol; 2013 Nov; 32(3):193-5. PubMed ID: 23218515
    [Abstract] [Full Text] [Related]

  • 7. Autocontouring and manual contouring: which is the better method for target delineation using 18F-FDG PET/CT in non-small cell lung cancer?
    Wu K, Ung YC, Hwang D, Tsao MS, Darling G, Maziak DE, Tirona R, Mah K, Wong CS.
    J Nucl Med; 2010 Oct; 51(10):1517-23. PubMed ID: 20847172
    [Abstract] [Full Text] [Related]

  • 8. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
    Spratt DE, Diaz R, McElmurray J, Csiki I, Duggan D, Lu B, Delbeke D.
    Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410
    [Abstract] [Full Text] [Related]

  • 9. 18F FDG PET/CT in a child with gliomatosis cerebri.
    Sürücü E, Mutafoğlu K, Ince D, Cakmakçı H, Demiral A, Polack BD.
    Rev Esp Med Nucl Imagen Mol; 2013 Apr; 32(4):273-4. PubMed ID: 23122744
    [No Abstract] [Full Text] [Related]

  • 10. Integrated FDG-PET/CT vs. standard radiological examinations: comparison of capability for assessment of postoperative recurrence in non-small cell lung cancer patients.
    Takenaka D, Ohno Y, Koyama H, Nogami M, Onishi Y, Matsumoto K, Matsumoto S, Yoshikawa T, Sugimura K.
    Eur J Radiol; 2010 Jun; 74(3):458-64. PubMed ID: 19398291
    [Abstract] [Full Text] [Related]

  • 11. Multiple leiomyosarcoma foci in 18F-FDG PET-CT.
    Sürücü E, Aslan M, Karahan P, Durak H.
    Rev Esp Med Nucl Imagen Mol; 2013 Jun; 32(4):269-70. PubMed ID: 23122743
    [No Abstract] [Full Text] [Related]

  • 12. F-18 FDG PET evaluation of bronchial plasmacytoma with CT and MRI correlation.
    Iagaru A, Mari C, Segall G.
    Clin Nucl Med; 2006 May; 31(5):279-80. PubMed ID: 16622337
    [No Abstract] [Full Text] [Related]

  • 13. Dual-time point scanning of integrated FDG PET/CT for the evaluation of mediastinal and hilar lymph nodes in non-small cell lung cancer diagnosed as operable by contrast-enhanced CT.
    Kasai T, Motoori K, Horikoshi T, Uchiyama K, Yasufuku K, Takiguchi Y, Takahashi F, Kuniyasu Y, Ito H.
    Eur J Radiol; 2010 Aug; 75(2):143-6. PubMed ID: 19446975
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inferior mesenteric venous thrombosis and 18F-FDG PET/CT.
    Peiró V, Alonso Farto JC, García Poza J, Alfonso JM.
    Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):55-6. PubMed ID: 23177347
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives.
    Nestle U, Kremp S, Grosu AL.
    Radiother Oncol; 2006 Nov; 81(2):209-25. PubMed ID: 17064802
    [Abstract] [Full Text] [Related]

  • 18. Detection of vascular malformation mimicking lung mass in 18F-FDG PET/CT.
    Orsal E, Seven B, Kursad Ayan A, Sahin A, Maman A.
    Rev Esp Med Nucl Imagen Mol; 2013 Nov; 32(6):400-1. PubMed ID: 23669272
    [No Abstract] [Full Text] [Related]

  • 19. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [Abstract] [Full Text] [Related]

  • 20. Pretherapy and posttherapy 18F-FDG PET/CT in isolated nasoseptal diffuse large B-cell lymphoma.
    Asa S, Aliyev A, Yılmaz S, Erkan ME, Sager S, Halac M.
    Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):62-3. PubMed ID: 23177348
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.